ZAVANTE THERAPEUTICS
Zavante is a clinical-stage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients.
ZAVANTE THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.zavante.com
Total Employee:
101+
Status:
Active
Contact:
(858)705-2365
Email Addresses:
[email protected]
Total Funding:
65 M USD
Technology used in webpage:
SPF Microsoft Azure DNS Microsoft Azure Twitter Tweet Button Facebook Like Button Mimecast Facebook Like CSC Global DNS FreshService
Similar Organizations
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
CMTx Biotech
CMTx Biotech focuses on repurposing a clinical-stage small molecule for the treatment of COVID-19 patients.
Opterion Health
Opterion Health is focused to bring innovation to dialysis care and foster home dialysis to improve the quality of life for patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Square 1 Bank
Square 1 Bank investment in Debt Financing - Zavante Therapeutics
Longitude Capital
Longitude Capital investment in Series A - Zavante Therapeutics
Aisling Capital
Aisling Capital investment in Series A - Zavante Therapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Zavante Therapeutics
Square 1 Bank
Square 1 Bank investment in Venture Round - Zavante Therapeutics
Official Site Inspections
http://www.zavante.com
- Host name: 165.160.15.20
- IP address: 165.160.15.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Zavante Therapeutics" on Search Engine
Commercial Stage Biopharmaceutical Company | Nabriva.com
Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections. Learn More. …See details»
Nabriva Acquires Zavante Therapeutics and its Late …
Jul 25, 2018 Shares of Nabriva Therapeutics are rising this morning after the company announced it acquired privately-held Zavante …See details»
Zavante Therapeutics - Crunchbase Company Profile & Funding
Company Type For Profit. Contact Email [email protected]. Phone Number (858)705-2365. Zavante is a clinical-stage biopharmaceutical company focused on developing novel …See details»
New Antibiotics | Nabriva Therapeutics | Nabriva.com
Acquired Zavante Therapeutics and CONTEPOâ„¢, a potential first-in-class injectable antibiotic in the United States for cUTIs. Submitted NDAs for CONTEPO to treat cUTIs, including acute pyelonephritis and lefamulin …See details»
After Zavante deal, Nabriva is poised to launch two first-in-class ...
Aug 17, 2018 On July 24, Nabriva Therapeutics announced the acquisition of Zavante Therapeutics, a biotechnology company developing treatments for the infections that …See details»
Avante! Startup Zavante heads for FDA with revamped antibiotic
Apr 6, 2017 Biotech. Avante! Startup Zavante heads for FDA with revamped antibiotic. By Phil Taylor Apr 6, 2017 9:36am. antibiotic-resistant bacteria antibiotics infectious disease …See details»
GAIN Act gives Zavante a shot at new antibiotic development
Apr 6, 2017 Zavante Therapeutics, a 2013 startup based in California, is repurposing an old oral antibiotic widely used in Europe as a U.S. intravenous drug. “One of the …See details»
Nabriva (NBRV) Reports Acquisition of Zavante Therapeutics
Jul 24, 2018 Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti …See details»
Nabriva Therapeutics acquires Zavante Therapeutics and with it …
Jul 28, 2018 Nabriva Therapeutics plc, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious …See details»
BioCentury - Nabriva acquires Zavante
Jaime De Leon. July 27, 2018 11:12 AM PDT. Nabriva Therapeutics plc (NASDAQ:NBRV) acquired Zavante Therapeutics Inc. (San Diego, Calif.) for 8.2 million Nabriva shares, or …See details»
Zavante Therapeutics Closes $45 Million Series A Financing In …
Mar 30, 2016 Zavante Therapeutics Closes $45 Million Series A Financing In Support Of U.S. Development For A First-In-Class Injectable Antibiotic. Proceeds to fund ZEUS …See details»
Zavante Announces FDA Endorsed ZTI-01 Development Plan to …
SAN DIEGO, Dec. 16, 2015 /PRNewswire/ -- Zavante Therapeutics, Inc., a privately-held, late stage clinical biopharmaceutical company, today announced that the U.S. Food and …See details»
Zavante Therapeutics acquired by Nabriva Therapeutics
Jul 25, 2018 Zavante Therapeutics Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients. Acquiring Organization: Nabriva …See details»
Nabriva Reports Acquisition of Zavante Therapeutics
Jul 29, 2018 Nabriva Therapeutics plc, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious …See details»
Nabriva Therapeutics Strengthens Antibiotics Leadership Position …
Jul 24, 2018 In addition, Zavante Therapeutics’ former stockholders are eligible to receive up to $97.5 million upon the achievement of specified regulatory and commercial …See details»
Nabriva snaps up Zavante for its market-ready antibiotic
GlobalData Healthcare August 2, 2018. Share this article. On July 24, 2018, Nabriva Therapeutics made the strategic acquisition of privately held Zavante Therapeutics …See details»
Zavante Therapeutics' ZOLYD™ Met Primary Endpoint In Pivotal …
Apr 6, 2017 Zavante Therapeutics, Inc. is a privately-held, late clinical-stage biopharmaceutical company focused on developing novel therapies to improve the …See details»
Zavante Therapeutics Announces Agreement With NIAID To …
Sep 8, 2017 Zavante Therapeutics, Inc. is a privately-held, late clinical-stage biopharmaceutical company focused on developing novel therapies to improve the …See details»
Zavante Therapeutics Reports ZOLYDâ„¢ Broad Spectrum
Jun 5, 2017 Zavante Therapeutics, Inc. is a privately-held, late clinical-stage biopharmaceutical company focused on developing novel therapies to improve the …See details»
Zavante Therapeutics - Funding, Financials, Valuation & Investors
Organization. Zavante Therapeutics. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Funding Rounds 4. Total …See details»